Coeptis Therapeutics (COEP) News Today $7.48 +0.09 (+1.22%) Closing price 04:00 PM EasternExtended Trading$7.40 -0.08 (-1.07%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock COEP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared - MorningstarJune 27, 2025 | morningstar.comMCoeptis Therapeutics Files Form S-4 Registration Statement for Proposed Merger with Z Squared Inc. - NasdaqJune 27, 2025 | nasdaq.comCoeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z SquaredJune 26, 2025 | globenewswire.comCoeptis Therapeutics (NASDAQ:COEP) Shares Down 6.7% - Should You Sell?June 24, 2025 | americanbankingnews.comSNAP Biosciences licenses Monarch’s cell therapy techMay 29, 2025 | investing.comMonarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in OncologyMay 28, 2025 | globenewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of ShareholdersMay 7, 2025 | morningstar.comMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of ShareholdersMay 1, 2025 | globenewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc. - COEPApril 28, 2025 | prnewswire.comBiopharma Firm Merges With Z Squared to Form Largest Publicly-Listed Dogecoin MinerApril 26, 2025 | news.bitcoin.comCoeptis Flops on Merger with Z SquaredApril 25, 2025 | baystreet.caCOEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to ShareholdersApril 25, 2025 | businesswire.comCoeptis Therapeutics Holdings, Inc. Enters Definitive Merger Agreement with Z Squared Inc. to Pursue Dogecoin Mining VentureApril 25, 2025 | quiverquant.comQCoeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger AgreementApril 25, 2025 | globenewswire.comCoeptis Therapeutics announces establishment of new technology hub in IndiaApril 18, 2025 | markets.businessinsider.comCOEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in TechnologyApril 17, 2025 | globenewswire.comCoeptis Therapeutics Holdings Inc. Common Stock (COEP) SEC FilingsMarch 19, 2025 | nasdaq.comCoeptis Inc. (COEP) Expands Cancer Immunotherapy Portfolio with Exclusive GEAR Cell Therapy LicenseMarch 14, 2025 | theglobeandmail.comCoeptis Therapeutics Secures Worldwide Rights To GEAR Cell Therapy PlatformMarch 13, 2025 | nasdaq.comCOEPTIS, Inc. Establishes GEAR Therapeutics to Advance Innovative Cancer Cell Therapy into First-in-Human StudiesMarch 13, 2025 | nasdaq.comCoeptis Therapeutics secures worldwide development rights to GEAR PlatformMarch 12, 2025 | markets.businessinsider.comCoeptis launches GEAR Therapeutics to develop innovative cancer cell therapiesMarch 12, 2025 | bizjournals.comCoeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology PipelineMarch 11, 2025 | globenewswire.comCOEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation PlanMarch 7, 2025 | globenewswire.comCOEP Stock trading resumesMarch 3, 2025 | markets.businessinsider.comCOEP Stock trading halted, volatility trading pauseMarch 3, 2025 | markets.businessinsider.comCoeptis Therapeutics’ NexGenAI partners with Arketyp ValuFebruary 20, 2025 | markets.businessinsider.comCoeptis’ NexGenAI Affiliates Network & MarketLeverage partner in marketingFebruary 20, 2025 | markets.businessinsider.comCOEPTIS' NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus NetworkFebruary 20, 2025 | globenewswire.comCOEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate MarketingFebruary 20, 2025 | globenewswire.comCOEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate MarketingFebruary 19, 2025 | globenewswire.comCoeptis launching investment armFebruary 17, 2025 | bizjournals.comCoeptis Therapeutics (COEP): Launching AI-Focused Venture Arm to Fuel InnovationFebruary 13, 2025 | insidermonkey.comCoeptis launches venture group for AI and automation startupsFebruary 13, 2025 | msn.comCOEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent StartupsFebruary 13, 2025 | globenewswire.comCoeptis Slides After New Round of FinancingFebruary 6, 2025 | baystreet.caCoeptis adds $5.7M to Series A, raises total to $10MFebruary 6, 2025 | bizjournals.comCOEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI IntegrationFebruary 6, 2025 | prnewswire.comCoeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare InnovationFebruary 1, 2025 | msn.comLocal biopharmaceutical company rebrands, embracing AI and blockchain technologiesJanuary 30, 2025 | bizjournals.comCoeptis Therapeutics shifts focus with rebrand and AI techJanuary 30, 2025 | msn.comCoeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and InnovationJanuary 30, 2025 | prnewswire.comCoeptis Therapeutics secures $1.1 million convertible noteJanuary 24, 2025 | msn.comCoeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation InnovationJanuary 23, 2025 | prnewswire.comCoeptis Therapeutics regains compliance with Nasdaq listing rulesJanuary 23, 2025 | markets.businessinsider.comCoeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)January 22, 2025 | prnewswire.comCoeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing PlatformJanuary 7, 2025 | prnewswire.comCoeptis Therapeutics Holdings Inc trading resumesJanuary 2, 2025 | markets.businessinsider.comCoeptis Therapeutics Holdings Inc trading halted, volatility trading pauseJanuary 2, 2025 | markets.businessinsider.comTrading Halt Occurred During This Micro Cap's EOY SurgeJanuary 1, 2025 | msn.com Get Coeptis Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COEP and its competitors with MarketBeat's FREE daily newsletter. Email Address COEP Media Mentions By Week COEP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COEP News Sentiment▼0.470.90▲Average Medical News Sentiment COEP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COEP Articles This Week▼41▲COEP Articles Average Week Get Coeptis Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COEP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cardiol Therapeutics News Atossa Genetics News Quantum Biopharma News C4 Therapeutics News Corbus Pharmaceuticals News OptiNose News Forte Biosciences News Cassava Sciences News Tenaya Therapeutics News Virios Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COEP) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
